Corbus Pharma (CRBP) Reports Q2 Loss of $0.11/Share

Corbus Pharma (NASDAQ: CRBP) reported Q2 EPS of ($0.11), versus ($0.10) reported last year.

For earnings history and earnings-related data on Corbus Pharma (CRBP) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• KB Home (KBH) Misses Q2 EPS by 2c; Offers Outlook
• St. James's Place plc (STJ:LN) (STJPF) PT Raised to GBP20.50 at Deutsche Bank